InvestorsHub Logo
icon url

powerwalker

11/13/21 10:21 PM

#335914 RE: falconer66a #335911

A division of the CDC, Autism and Developmental Disabilities Monitoring, published a report stating that one in 54 U.S. children has autism. While the number has steadily increased over the years, that does not mean more people are developing the disorder, just that doctors are able to diagnose more accurately.



https://www.tpathways.org/faqs/how-many-people-have-autism/

Many of us here know that Anavex 2-73 will help these kids one way or the other. It is time the fda allows for some novel treatments for the sake of the children and their families.


ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
icon url

Talon38

11/13/21 10:31 PM

#335917 RE: falconer66a #335911

Agree wholehearted with you Falconer. The digram of our drugs and planned clinical trials has a orange bordered arrow indicating a P2/3 for Fragile X, thus is consequently in the planning phase. Our former FDA managers may be working a trial architecture with the FDA that will enable "Blanket Trial" expansion into other autism spectrum diseases. This is especially true of those which have uncontrollable body movements/spasms (like Rett, Frail X, Infantile Spasms, and Angelman's).
icon url

plexrec

11/14/21 8:06 AM

#335937 RE: falconer66a #335911

" Anavex fragile X syndrome clinical trial should be illuminating; "--optimistic here--2-73 will be helpful for a broad range of CNS conditions-"complete housecleaning"---autism-Als-epilepsy--and more !!! hold your shares !!!!!